IRS2 and cancer: BRAF, PIK3R5, NFKB1, NRAS, IRS2, FOXO1, SHIP1, IRS4, PIK3CA, MTOR, PIK3R1, PIK3R4, and PTEN each had more than 1 somatic mutation and constitute reasonable candidate cancer driver genes.